2015年9月11日 Posted by aihara

ワークショップの課題とパネリストへの質問 (IOM)

診療ガイドライン作成にあたって、パネリストには具体的にどのような質問をすべきなのだろうか。

IOMの信頼できる診療ガイドライン(Clinical practice guidelines we can trust)に記載されている、「ワークショップの課題とパネリストへの質問」(Appendix B)で、2010年1月のWashington, DCで開催されたワークショップで利用されたものが以下です(フリーで公開されているものなので、紹介します)。

Questions for the Panelists

What do you believe are the biggest challenges clinical practice guidelines developers/users face today? For example:

  • What do you do when the scientific evidence is absent or poor?
  • How do you reconcile disagreements in evidence interpretation among guidelines?
  • How do guidelines accommodate subgroups (e.g., older populations or persons with multimorbidities) whose treatment outcomes may differ from the average patient?
  • Are there other challenges you believe are important?

What topics and/or processes do you think the committee should consider in deriving quality standards for clinical practice guidelines? For example:

  • What should the composition of CPG development panels,in particular the balance of methodologists, topical experts, and consumers, look like?
  • What methods might be developed for determining which recommendations among those in a guideline should be applied to quality measures or electronic medical record decision prompts?
  • Is there an available assessment tool that adequately rates both the level of the scientific evidence and strength of clinical recommendations that should be used as standard practice in guideline development?
  • What administrative (e.g., accreditation) or legal approaches might improve the quality of clinical practice guidelines?
  • What explicit approaches might harmonize guideline developers and increase guidelines convergence?
  • What types of strategies might promote greater use of guidelines?
  • Are there other characteristics of guideline standards you think are important for the committee to consider?

上記を翻訳したものが、こちらです.(WORDPDF)。

About aihara

Gordon GuyattやHolger Schunemann、Yngve Falck-YtterらとともにGRADE working groupメンバーとして、GRADEシステムの適切な普及につとめています。

Comments are closed.